PPLPHARMA - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 05 Nov 25, 7:43 am

Technical Rating: 3.8

📊 Technical Analysis Summary

• Trend Status: Consolidating with bullish undertone
• Current Price: ₹200
• RSI (55.1): Neutral to bullish — moderate strength
• MACD (1.52): Positive crossover — early bullish signal
• Volume: Above average (26.05L vs 23.70L) — rising interest
• DMA 50/200: Price between 50 DMA (₹198) and 200 DMA (₹203) — indecisive but stabilizing
• Bollinger Bands: Price near mid-band — potential for breakout

📈 Entry & Exit Zones

• Support Levels: ₹195 / ₹185 / ₹180
• Resistance Levels: ₹210 / ₹225 / ₹250
• Optimal Entry: ₹195–₹200 (on dip near support)
• Exit Target: ₹225–₹250 (if momentum sustains)

✅ Positive

• MACD and volume trends support bullish momentum
• PEG ratio of 1.66 — reasonable valuation for growth
• Low debt-to-equity (0.17) — financially stable

⚠️ Limitation

• Price hovering between moving averages — no clear trend
• Dividend yield is minimal (0.07%)
• ROCE (12.4%) and ROE (9.74%) — moderate efficiency

📉 Company Negative News

• FII holding declined by 0.59% — foreign investor caution
• Stock down 15.2% over 52 weeks — underperformance

📈 Company Positive News

• DII holding increased by 0.64% — domestic investor support
• Quarterly PAT of ₹113 Cr — recovering from prior ₹277 Cr loss

🏢 Industry

• PPLPHARMA operates in pharmaceuticals — defensive and innovation-driven sector
• Industry P/E is 33.1 vs PPLPHARMA’s 36.9 — slightly overvalued
• Sector benefits from healthcare demand and regulatory tailwinds

🧾 Conclusion

• PPLPHARMA is currently consolidating with early signs of bullish momentum
• Entry near ₹195–₹200 may offer upside toward ₹225–₹250
• Valuation and fundamentals support medium-term accumulation with technical confirmation